Drug Nomenclature and Classification

Drug nomenclature and classification are foundational to pharmaceutical sciences, clinical pharmacology, regulatory affairs, and healthcare communication. Proper naming and classification of drugs ensure consistency in prescribing, dispensing, research, regulation, and pharmacovigilance. Drug names and classes convey essential information about a compound’s structure, origin, pharmacological effect, therapeutic use, and legal status. Given the vast and growing pharmacopeia, a well-established system of nomenclature and classification is vital to managing medication safety, regulatory compliance, and global standardization.

This professional exposition presents a comprehensive analysis of drug naming conventions (nomenclature), international standards, chemical and proprietary names, classification systems, regulatory frameworks, challenges, and the evolving role of pharmacoinformatics.

---

1. Introduction to Drug Nomenclature

Drug nomenclature refers to the systematic naming of pharmaceutical substances. A single drug typically has multiple names, each serving a distinct purpose in scientific, regulatory, or commercial contexts.

A. Key Drug Names

1. Chemical Name

   • Describes the drug’s molecular structure and chemical composition.

   • Used primarily by chemists and in scientific research.

   • Example: N-acetyl-p-aminophenol (for paracetamol/acetaminophen)

2. International Nonproprietary Name (INN)

   • Standardized generic name assigned by the World Health Organization (WHO).

   • Universally accepted and used in labeling, formularies, and education.

   • Example: Paracetamol (INN for acetaminophen)

3. United States Adopted Name (USAN)

   • Generic name approved for use in the U.S., often aligned with INN.

   • Example: Acetaminophen (USAN for paracetamol)

4. Brand (Trade/Proprietary) Name

   • Registered name assigned by a pharmaceutical company.

   • Protected by trademark law.

   • Example: Tylenol (brand name for acetaminophen)

5. Code Name or Development Name

   • Used during drug discovery and clinical trials.

   • Often alphanumeric.

   • Example: AZT (code name for zidovudine)

---

2. Principles of Drug Naming (INN System)

The World Health Organization (WHO) assigns INNs based on clear, globally recognized guidelines. The objective is to provide a unique, nonproprietary name that reflects the drug’s pharmacological or chemical characteristics.

INN Construction Guidelines:

• Stems (suffixes or infixes) indicate drug class or action.

• Names are unique, not confusingly similar to existing drugs.

• Avoids promotional or brand-like elements.

• Names are pronounceable and appropriate across multiple languages.

Examples of INN Stems:

Stem	Indicates	Examples
–pril	ACE inhibitors	Enalapril, Ramipril
–sartan	ARBs	Losartan, Valsartan
–olol	Beta-blockers	Atenolol, Propranolol
–mab	Monoclonal antibodies	Trastuzumab, Adalimumab
–statin	HMG-CoA reductase inhibitors	Atorvastatin, Simvastatin
–cillin	Penicillins	Amoxicillin, Benzylpenicillin
–prazole	Proton pump inhibitors	Omeprazole, Lansoprazole

3. Drug Classification Systems

Drug classification is the systematic categorization of drugs based on structure, mechanism of action, therapeutic use, or legal status. It facilitates drug regulation, education, clinical decision-making, and pharmaceutical research.

A. Anatomical Therapeutic Chemical (ATC) Classification System

Developed by the WHO Collaborating Centre for Drug Statistics Methodology, the ATC system classifies drugs according to:

1. Anatomical group (e.g., cardiovascular system)

2. Therapeutic subgroup (e.g., antihypertensives)

3. Pharmacological subgroup (e.g., ACE inhibitors)

4. Chemical subgroup

5. Chemical substance

Example:
ATC code for enalapril: C09AA02

• C = Cardiovascular system

• C09 = Agents acting on renin-angiotensin system

• C09A = ACE inhibitors

• C09AA = Plain ACE inhibitors

• C09AA02 = Enalapril

B. Therapeutic Classification

Groups drugs based on disease treated or therapeutic indication.

Therapeutic Class	Examples
Antihypertensives	Amlodipine, Lisinopril
Antidiabetics	Metformin, Insulin
Antidepressants	Sertraline, Fluoxetine
Antineoplastics	Cisplatin, Paclitaxel

C. Pharmacological or Mechanistic Classification

Organizes drugs by mechanism of action at cellular/molecular levels.

Mechanism Class	Examples
Beta-adrenergic blockers	Atenolol, Bisoprolol
Dopamine agonists	Pramipexole, Ropinirole
Proton pump inhibitors	Esomeprazole, Rabeprazole

D. Chemical Classification

Categorizes drugs based on chemical structure.

Chemical Class	Examples
Benzodiazepines	Diazepam, Lorazepam
Sulfonylureas	Glipizide, Glyburide
Fluoroquinolones	Ciprofloxacin, Levofloxacin

E. Legal or Regulatory Classification

Defined by laws, regulatory agencies, or scheduling systems.

Legal Class	Examples
Prescription-only (Rx)	Morphine, Atorvastatin
Over-the-counter (OTC)	Paracetamol, Ibuprofen
Controlled substances (Schedule I–V, DEA)	Schedule II: Oxycodone; Schedule V: Lomotil
Orphan drugs	Nitisinone, Ivacaftor

4. Regulatory Authorities and Naming Conventions

Agency	Jurisdiction	Functions
WHO-INN	Global	Assigns INNs
FDA (U.S.)	United States	Approves USAN, brand names, and labeling
EMA	European Union	Monitors INNs and brand names
MHRA	UK	National drug classification and name approvals
Health Canada	Canada	Reviews DIN and name safety
TGA	Australia	Regulates medicine names and classifications

5. Examples of Drug Nomenclature Across Categories

Drug Name	Chemical Name	INN (Generic)	Brand
Aspirin	Acetylsalicylic acid	Acetylsalicylic acid	Bayer, Disprin
Tylenol	N-acetyl-p-aminophenol	Paracetamol	Tylenol
Lipitor	(3R,5R)-7-[2-(4-Fluorophenyl)-...]	Atorvastatin	Lipitor
Prozac	N-methyl-3-phenyl-3-[...]-amine	Fluoxetine	Prozac
Humira	Recombinant human IgG1 mAb	Adalimumab	Humira

6. Special Categories of Drug Naming

A. Biologics and Monoclonal Antibodies

Use complex suffix conventions:

• –mab: Monoclonal antibody

• –cept: Fusion proteins (e.g., Etanercept)

• Naming includes:

  • Target: –tu– for tumors, –li– for immunomodulating

  • Source: –u– for human, –xi– for chimeric

Example: Trastuzumab

• trast– (prefix)

• –zu– (humanized)

• –mab (monoclonal antibody)

B. Biosimilars

Named using a nonproprietary base name + suffix in the U.S.
Example: Adalimumab-atto

C. Vaccines

Named based on target pathogen, platform, and manufacturer.

D. Radiopharmaceuticals

Include radionuclide and ligand names (e.g., Technetium Tc-99m medronate)

---

7. Drug Classification in Formularies and Pharmacopoeias

• British National Formulary (BNF): Therapeutic classification used in UK hospitals

• United States Pharmacopeia (USP): Standards for drug identity and purity

• Martindale: The Complete Drug Reference: Global drug index

• National Drug Code (NDC, USA): Tracks manufacturer, product, and package

---

8. Drug Databases and Informatics Tools

Tool	Function
RxNorm (U.S.)	Provides normalized drug naming for EHRs
DailyMed	Drug labeling information from FDA
Drugs.com	Public database with classification and nomenclature
DrugBank	Bioinformatics drug repository
PharmGKB	Pharmacogenomic classifications
MIMS	Prescriber information and classifications

9. Challenges in Drug Nomenclature and Classification

• Name Confusion (Look-Alike Sound-Alike): E.g., Celebrex vs. Celexa

• Brand proliferation: Multiple branded versions cause confusion

• Cross-border inconsistencies: Different INNs or brand names in countries

• Off-label use: Misalignment with classification

• Combination drugs: Difficult to classify under single categories

---

10. Future Directions and Innovations

A. AI and Ontology-Driven Classifications

• Natural language processing (NLP) for standardizing drug data

• Integration with EHR and CDS (clinical decision support)

B. Personalized Classification

• Based on genomic, proteomic, or metabolomic drug response

C. Unified Global Registries

• Efforts to standardize drug information across jurisdictions

D. Enhanced Pharmacovigilance Classification

• Risk-based classifications for monitoring adverse events